Researchers centered at Nagoya University develop a nanowire device able to detect microscopic levels of urinary markers potentially implicated in cancer
Cells communicate with each other through a number of different mechanisms. Some of these mechanisms are well-known: in animals, for example, predatory threats can drive the release of norepinephrine, a hormone that travels through the bloodstream and triggers heart and muscle cells to initiate a “fight-or-flight” response.
A far less familiar mode of cellular transport is the extracellular vesicle (EV). EVs can be thought of as small “chunks” of a cell that are able to pinch off and circulate throughout the body to deliver messenger cargo to other cells. These messengers have become increasingly recognized as crucial mediators of cell-to-cell communication.
In a new study reported in Science Advances, researchers centered at Nagoya University have developed a novel medical device that can efficiently capture these EVs, and potentially use them to screen for cancer.
Video 1: MicroRNA extraction using nanowires
After introducing a urine sample onto the device, extracellular vesicles are captured by a nanowire substrate via electrostatic forces. MicroRNAs can then be directly extracted from the substrate. Takao Yasui
“EVs are potentially useful as clinical markers. The composition of the molecules contained in an EV may provide a diagnostic signature for certain diseases,” lead author Takao Yasui explains. “The ongoing challenge for physicians in any field is to find a non-invasive diagnostic tool that allows them to monitor their patients on a regular basis–for example, a simple urine test.”
Among the many molecules EVs have been found to harbor are microRNAs, which are short pieces of ribonucleic acid that play diverse roles in normal cellular biology. Critically, the presence of certain microRNAs in urine might serve as a red flag for serious conditions such as bladder and prostate cancer. While this important cargo could therefore theoretically aid physicians in cancer diagnoses, there are still many technological hurdles that need to be overcome. One such hurdle: finding a feasible method to capture EVs in sufficient quantities to analyze them in a routine clinical setting.
“The content of EVs in urine is extremely low, at less than 0.01% of the total fluid volume. This is a major barrier to their diagnostic utility,” Yasui notes. Our solution was to embed zinc oxide nanowires into a specialized polymer to create a material that we believed would be highly efficient at capturing these vesicles. Our findings suggest that the device is indeed quite efficient. We obtained a collection rate of over 99%, surpassing ultracentrifugation as well as other methods that are currently being used in the field.”
To test the practicality of their device, the research team compared the microRNAs of EVs isolated from healthy patients with those isolated from patients who were already diagnosed with bladder, prostate, and other forms of cancer. Notably, their technique required only 1 milliliter of urine–far more than the typical “deposit” provided during a routine checkup–and found a substantially greater number and different types of microRNAs compared with the standard ultracentrifugation approach.
Figure 2: Identification of distinct microRNA patterns in healthy donors and cancer patients
Nanowire extraction allowed many microRNAs to be compared at once using urine samples collected from patients. Expression of each microRNA is shown as low/downregulated (blue), intermediate (black), or high/upregulated (yellow). The analysis reveals unique patterns of expression for groups of microRNAs when comparing healthy donors (?) with cancer patients (+). via Takao Yasui
“Finding a specific, reproducible marker to help confirm a cancer diagnosis is difficult. This is especially true for microRNAs, which are a relatively new class of markers in the field,” co-author Yoshinobu Baba explains. “Sometimes finding just one reliable microRNA is considered a success. Using this approach, we were surprised to find that not just one, but whole combinations of microRNAs might be associated with different types of cancers. The findings are preliminary, of course, but we hope our device can help to lay the groundwork for easier ways to diagnose life-threatening diseases as early as possible.”
Learn more: Development of a Nanowire Device to Detect Cancer with a Urine Test
The Latest on: Detecting cancer
[google_news title=”” keyword=”detecting cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Dozens attend prostate cancer early detection event in Isle of Wight Co.on April 27, 2024 at 9:34 am
Men packed a community room in a Rushmere-area church on Saturday to learn about prostate cancer before getting screened.
- Chinese AI innovation identifies oesophageal cancer lesions at double rate of doctors’ assessment by eye: paperon April 27, 2024 at 5:00 am
Algorithm that highlights lesions on the gullet for doctors during an endoscopy is now used in hundreds of hospitals in China Early detection is key as the cancer has five-year survival rate of more ...
- Medicare Refusing to Pay for Cancer Scan Sparks Warning for Patientson April 26, 2024 at 8:39 am
When it comes to breast cancer screening, women are often told they need an additional scan beyond just a mammogram because these scans can miss tumors in women with dense breast tissue. However, ...
- New method could detect early ovarian cancer from urine samples,claims researchon April 25, 2024 at 3:45 pm
New research by Joseph Reiner and colleagues at Virginia Commonwealth University shows promise for a urine-based test for ovarian cancer. Reiner will present their research at the 68th ...
- Researchers create an AI-powered digital imaging system to speed up cancer biopsy resultson April 25, 2024 at 6:55 am
University of Waterloo researchers have invented a digital medical imaging system that significantly improves the cancer detection process to deliver immediate results and enable swift, effective ...
- Company developing early cancer-detection tests to cut 20% of workforceon April 24, 2024 at 7:35 am
Early cancer-detection test maker that raised $254 million earlier this year now says it will cut more than 100 jobs — about 20% of its workforce — as it restructures ...
- Balancing hope and reality: The promise and peril of blood-based colorectal cancer screeningon April 24, 2024 at 1:30 am
A simple blood test to detect colorectal cancer sounds amazing. But unlike colonoscopy, a blood test can't remove precancerous polyps.
- Urine-based test detects head and neck canceron April 23, 2024 at 4:15 am
While the initial study focused on head and neck cancer, the team also analyzed urine samples of people with other cancers, such as breast and acute myeloid leukemia, and found that ultrashort ...
- Detecting cancer in minutes possible with just a drop of dried blood and new test, study hintson April 22, 2024 at 9:19 am
Early tests suggest that a new tool that requires only a single drop of blood could detect three of the deadliest forms of cancer.
- Researchers discover urine-based test to detect head and neck canceron April 17, 2024 at 5:31 am
Researchers have created a urine-based test that detects pieces of DNA fragments released by head and neck tumors. The test could potentially facilitate early detection of this cancer type, which ...
via Google News and Bing News